Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fishbane

Showing results (91-100 of 357) with videos related to

Pageof 36
Sort By:
Kidney International|June 29, 2007
The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?S Fishbane, A R Nissenson
Seminars in Dialysis|January 15, 2009
Current issues in iron management in end-stage renal diseaseS Fishbane, J K Maesaka
Nature Reviews. Nephrology|August 6, 2014
Anaemia: FIND-CKD: intravenous iron in predialysis CKDSteven Fishbane, Azzour D Hazzan
Seminars in Dialysis|March 7, 2018
Is there an established hemoglobin target range for patients undergoing chronic dialysis?Hitesh H Shah, Steven Fishbane
Clinical Nephrology|April 28, 2018
Cyclical cardiorenal syndrome in late-stage kidney disease
Benson S Ku, Steven Fishbane
Clinical Journal of the American Society of Nephrology : CJASN|August 13, 2024
Automated Dialysis Anemia Management: Role of the Treating NephrologistSteven Fishbane, Hitesh H Shah
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 18, 1998
Regulation of renal urate excretion: a critical reviewJ K Maesaka, S Fishbane
Nephrology News & Issues|July 17, 2013
Choice of erythropoiesis stimulating agent in ESRDSteven Fishbane, Hitesh H Shah
Clinical Journal of the American Society of Nephrology : CJASN|July 18, 2015
Quality Measurement in Wonderland: The Curious Case of a Dialysis Readmissions MeasureSteven Fishbane, Jay B Wish
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 2, 2020
Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19Steven Fishbane, Jamie S Hirsch
Pageof 36

Showing results (91-100 of 357) with videos related to

Sort By:
Pageof 36
Kidney International|June 29, 2007
The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?S Fishbane, A R Nissenson
Seminars in Dialysis|January 15, 2009
Current issues in iron management in end-stage renal diseaseS Fishbane, J K Maesaka
Nature Reviews. Nephrology|August 6, 2014
Anaemia: FIND-CKD: intravenous iron in predialysis CKDSteven Fishbane, Azzour D Hazzan
Seminars in Dialysis|March 7, 2018
Is there an established hemoglobin target range for patients undergoing chronic dialysis?Hitesh H Shah, Steven Fishbane
Clinical Nephrology|April 28, 2018
Cyclical cardiorenal syndrome in late-stage kidney disease
Benson S Ku, Steven Fishbane
Clinical Journal of the American Society of Nephrology : CJASN|August 13, 2024
Automated Dialysis Anemia Management: Role of the Treating NephrologistSteven Fishbane, Hitesh H Shah
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 18, 1998
Regulation of renal urate excretion: a critical reviewJ K Maesaka, S Fishbane
Nephrology News & Issues|July 17, 2013
Choice of erythropoiesis stimulating agent in ESRDSteven Fishbane, Hitesh H Shah
Clinical Journal of the American Society of Nephrology : CJASN|July 18, 2015
Quality Measurement in Wonderland: The Curious Case of a Dialysis Readmissions MeasureSteven Fishbane, Jay B Wish
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 2, 2020
Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19Steven Fishbane, Jamie S Hirsch
Pageof 36